Comments Regarding Quantitative Labeling of Sodium, Potassium, and Phosphorus for OTC and Prescription Drug Products Share page: Docket Number: FDA-2021-D-0528 Download Document Issues: OTC Medicines Other Issues Labeling Quality Related Posts Switch List Articles 2023 Outlook for Consumer Healthcare Jan 9, 2023 CHPA Q&A: Update on OTC Children's Pain Relievers and Fever Reducers